Home/Filings/4/0001437749-21-027688
4//SEC Filing

Mikhail Michel 4

Accession 0001437749-21-027688

CIK 0000810509other

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 4:08 PM ET

Size

5.1 KB

Accession

0001437749-21-027688

Insider Transaction Report

Form 4
Period: 2021-11-15
Mikhail Michel
Chief Regulatory Officer
Transactions
  • Award

    Stock Option

    2021-11-15$0.00/sh+75,000$7575,000 total
    Exercise: $1.37Exp: 2031-11-15Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-third on each of the first three anniversaries of the date of grant.

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeother

Related Parties

1
  • filerCIK 0001886391

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:08 PM ET
Size
5.1 KB